SCHEMBL3169205

SCHEMBL3169205

Oc1cccc(O)c1C1CCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
CNR1 P21554 6/20 0.40
CNR2 P34972 5/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ADAMTS4 O75173 1/20 0.39
ALDH1A1 P00352 1/20 0.39
EGFR P00533 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 1/20 0.39
FYN P06241 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7531576 0.98 HDAC4 (0.50) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL6004412 0.98 HDAC4 (0.50) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL4962052 0.87 CHRNB2 (0.55) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL4961704 0.85 CHRNB2 (0.53) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL10892675 0.85 TRPA1 (0.50) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL4962002 0.85 CHRNB2 (0.53) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL901458 0.85 CHRNB2 (0.53) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL11751246 0.85 TSHR (0.45) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL4958023 0.85 CHRNB2 (0.53) HDAC4HDAC2HDAC8CHRNB2CHRNA4
SCHEMBL4961639 0.85 CHRNB2 (0.53) HDAC4HDAC2HDAC8CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858217-B2 Stabilization of terpenoids in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) 2005-02-22 US claimed
US-20030185867-A1 Stabilization of terpenoids in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-10-02 US claimed
WO-2003080011-A1 STABILIZATION OF TERPENOIDS IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
US-11337908-B2 Personal care compositions with cystine CONOPCO, INC. (US) 2022-05-24 US disclosed
US-20200222293-A1 PERSONAL CARE COMPOSITIONS WITH CYSTINE CONOPCO, INC.,D/B/A UNILEVER (US) 2020-07-16 US disclosed
CN-110121331-A Personal care compositions containing poorly soluble compounds 荷兰联合利华有限公司 2019-08-13 CN disclosed
CN-106470660-A Stabilized skin care compositions containing nitrogen boranes 荷兰联合利华有限公司 2017-03-01 CN disclosed
EP-1592397-B1 IMPROVED FORMULATION FOR SKIN-LIGHTENING AGENTS WARNER LAMBERT CO (US) 2010-03-31 EP disclosed
CN-100577623-C Decolorizing agent WARNER LAMBERT CO 2010-01-06 CN disclosed
CN-101544542-A Depigmentation agents WARNER LAMBERT CO 2009-09-30 CN disclosed
EP-1628945-B1 DEPIGMENTING AGENTS WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
CN-1284521-A Aromatic ester compound and its prep., expoxy resin composition using the same and coper-coated laminate SUMITOMO CHEMICAL CO (JP) 2001-02-21 CN disclosed
CN-1060771-C Aryl ester compound, process for producing the same, epoxy resin composition using the same, and copper-clad laminate using the same SUMITOMO CHEMICAL CO (JP) 2001-01-17 CN disclosed
EP-0811619-B1 Novel ester compound and thermosetting resin composition using the same SUMITOMO CHEMICAL CO (JP) 2000-09-27 EP disclosed
US-5916683-A Copper-clad laminate with prepreg of epoxy resin and aryl ester SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1999-06-29 US disclosed
US-5726257-A Esterified resorcinol-carbonyl compound condensates and epoxy resins therewith SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1998-03-10 US disclosed
CN-1170710-A Novel ester compound and themrosetting resin composition using the same SUMITOMO CHEMICAL CO (JP) 1998-01-21 CN disclosed
EP-0811619-A1 Novel ester compound and thermosetting resin composition using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-12-10 EP disclosed
CN-1125218-A Novel aryl ester compound, process for producing the same, epoxy resin composition using the same, and copper-clad laminate using the same SUMITOMO CHEMICAL CO (JP) 1996-06-26 CN disclosed
EP-0699670-A2 Aryl ester compound, its production process, epoxy resin composition using said compound, and copper-clad laminate using the epoxy resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-03-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030185867-A1 Stabilization of terpenoids in cosmetic compositions SQLE, CYP51A1, RBP4 HDAC4 224/4885HDAC2 1249/4885HDAC8 910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.